Australia reviews asthma treatment protocols for children

02/20/2013 | BioSpectrum Asia

Australia is examining the problem of treating asthmatic children with fixed dose combinations without first prescribing a single-ingredient product (inhaled corticosteroid), a practice that goes against the prevailing asthma management guidelines. The country's main pediatric advisory group considers extensive FDC use to be a serious issue of quality medical care.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD